Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.

Bohr A, Nascimento TL, Harmankaya N, Weisser JJ, Wang Y, Grohganz H, Rades T, Löbmann K.

Molecules. 2019 Jan 11;24(2). pii: E266. doi: 10.3390/molecules24020266.

2.

Poly(ethylene carbonate)-containing polylactic acid microparticles with rifampicin improve drug delivery to macrophages.

Priemel PA, Wang Y, Bohr A, Water JJ, Yang M, Mørck Nielsen H.

J Pharm Pharmacol. 2018 Aug;70(8):1009-1021. doi: 10.1111/jphp.12937. Epub 2018 May 30.

PMID:
29851078
3.

Investigation of nanocarriers and excipients for preparation of nanoembedded microparticles.

Wang Y, Beck-Broichsitter M, Yang M, Rantanen J, Bohr A.

Int J Pharm. 2017 Jun 30;526(1-2):300-308. doi: 10.1016/j.ijpharm.2017.05.008. Epub 2017 May 4.

PMID:
28479517
4.

Molecular weight-dependent degradation and drug release of surface-eroding poly(ethylene carbonate).

Bohr A, Wang Y, Harmankaya N, Water JJ, Baldursdottír S, Almdal K, Beck-Broichsitter M.

Eur J Pharm Biopharm. 2017 Jun;115:140-148. doi: 10.1016/j.ejpb.2017.02.011. Epub 2017 Feb 24.

PMID:
28238837
5.

High-Throughput Fabrication of Nanocomplexes Using 3D-Printed Micromixers.

Bohr A, Boetker J, Wang Y, Jensen H, Rantanen J, Beck-Broichsitter M.

J Pharm Sci. 2017 Mar;106(3):835-842. doi: 10.1016/j.xphs.2016.10.027. Epub 2016 Dec 6.

PMID:
27938892
6.

Potential of surface-eroding poly(ethylene carbonate) for drug delivery to macrophages.

Bohr A, Water JJ, Wang Y, Arnfast L, Beck-Broichsitter M.

Int J Pharm. 2016 Sep 25;511(2):814-20. doi: 10.1016/j.ijpharm.2016.07.075. Epub 2016 Aug 1.

PMID:
27492019

Supplemental Content

Loading ...
Support Center